LIQUIDIA CORPORATION - COMMON STOCK

Liquidia Announces Closing of Public Offering of Common Stock and Full Exercise of Over-Allotment Option

18 4月 2022 15:05:20 条件 Nasdaq GlobeNewswire

Liquidia Announces Pricing of Public Offering of Common Stock

12 4月 2022 20:38:07 条件 Nasdaq GlobeNewswire

Liquidia Announces Proposed Offering of Common Stock

12 4月 2022 15:17:43 条件 Nasdaq GlobeNewswire

Liquidia Corporation Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

22 3月 2022 15:30:52 条件 Nasdaq GlobeNewswire

Liquidia Corporation Reports Full-Year 2021 Financial Results and Provides Corporate Update

17 3月 2022 05:30:57 条件 Nasdaq GlobeNewswire

Liquidia Corporation to Report Full Year 2021 Financial Results on Thursday, March 17, 2022

10 3月 2022 06:00:37 条件 Nasdaq GlobeNewswire

Liquidia Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

23 2月 2022 05:30:00 条件 Nasdaq GlobeNewswire

Liquidia Re-Finances Debt Facility With Silicon Valley Bank To Increase To $40.0 Million

07 1月 2022 08:02:51 条件 Nasdaq GlobeNewswire

Liquidia Corporation Announces Chief Executive Officer Transition

03 1月 2022 15:52:06 条件 Nasdaq GlobeNewswire

Stipulation of Partial Judgment In Favor of Liquidia Filed In Hatch-Waxman Litigation

29 12月 2021 05:45:00 条件 Nasdaq GlobeNewswire

Liquidia to Participate in the Jefferies London Healthcare Conference

11 11月 2021 15:30:00 条件 Nasdaq GlobeNewswire

FDA Grants Tentative Approval for Liquidia’s YUTREPIA™ (Treprostinil) Inhalation Powder

08 11月 2021 04:45:00 条件 Nasdaq GlobeNewswire

Liquidia Reports Third Quarter 2021 Financial Results and Provides Corporate Update

03 11月 2021 15:56:12 条件 Nasdaq GlobeNewswire

Liquidia Receives Favorable Ruling in Inter Partes Review against United Therapeutics Patent

08 10月 2021 16:23:01 条件 Nasdaq GlobeNewswire

Liquidia to Participate at H.C. Wainwright 23rd Annual Global Investment Conference

10 9月 2021 07:29:01 条件 Nasdaq GlobeNewswire

FDA Completes On-site Pre-Approval Inspection of Liquidia’s Morrisville, North Carolina Facility

18 8月 2021 15:15:00 条件 Nasdaq GlobeNewswire

U.S. Patent Trial and Trademark Appeal Board Decides to Institute Inter Partes Review of United Therapeutics’ Tyvaso® Patent

12 8月 2021 07:00:01 条件 Nasdaq GlobeNewswire

Liquidia Reports Second Quarter 2021 Financial Results and Provides Corporate Update

10 8月 2021 06:00:01 条件 Nasdaq GlobeNewswire

Liquidia to Report Second Quarter 2021 Financial Results on August 10, 2021

03 8月 2021 06:00:01 条件 Nasdaq GlobeNewswire

Liquidia Announces FDA Acceptance of New Drug Application Resubmission for LIQ861 (treprostinil) Inhalation Powder

02 6月 2021 06:00:00 条件 Nasdaq GlobeNewswire